In a new study, researchers treated certain types of breast cancer cells in the lab with metformin, a medication used to help lower the blood sugar levels of people with type 2 diabetes. With less sugar to feed on, these cells developed a sugar “addiction,” which made them work harder to break down the sugar. That extra effort, in turn, made the cancer more vulnerable to treatment with anticancer drugs. Researchers found that when metformin was combined with a cancer treatment, the cancer cells’ growth slowed by 76 percent. This new approach is particularly promising for treating triple-negative breast cancer, an aggressive form of the disease that doesn’t respond well to existing treatments.
ANTIBACTERIAL CLEANERS MAY HELP FUNGI FLOURISH
You can read upto 3 premium stories before you subscribe to Magzter GOLD
Log-in, if you are already a subscriber
Get unlimited access to thousands of curated premium stories and 5,000+ magazines
READ THE ENTIRE ISSUE